logo
How On the Goga is reimagining corporate employee wellness programs

How On the Goga is reimagining corporate employee wellness programs

Technical.ly03-07-2025
Startup profile: On the Goga
Founded by: Anna Greenwald
Year founded: 2015
Headquarters: Philadelphia, PA
Sector: Healthcare
Funding and valuation: $1.3 million in funding, according to the company
Key ecosystem partners: PIDC, Ben Franklin Technology Partners, University of Pennsylvania
Anna Greenwald didn't dream of being a wellness entrepreneur.
She came to Philadelphia from Madison, Wisconsin, in 2011 as an aspiring opera singer with an interest in entrepreneurship, attending Drexel University's music industry program.
When a vocal cord injury derailed her plans, leaving her emotionally devastated, Greenwald's physician insisted she start taking yoga.
'My first thought was, absolutely not,' Greenwald, now the founder and CEO of the corporate wellness platform On the Goga, told Technical.ly. 'I'm not a hippie, and I hate exercise, so why would I try yoga?'
On the Goga — the name a mashup of 'on the go' and 'yoga' — is now a national employee wellness platform serving a diverse array of clients, from small companies to large enterprises. With a recent $300,000 seed extension and a mission to transform corporate wellness, the company is leveraging technology, AI and a pre-clinical approach to employee well-being.
While employee behavior tracking is becoming increasingly popular with corporations, On the Goga doesn't incorporate individual monitoring into its platform, instead collecting the broader organizational data, aggregating it and shares findings with clients that they can act on.
'We can share insights to employers to say, hey, the top driver of burnout for your employees is meeting schedules,' Greenwald said. While the platform doesn't flag clients when employees may need clinical intervention, it acts as an integrator, making clinical employee resources, such as therapy benefits offered by the company, visible on the platform.
A decade and two business models in, the company continues to evolve and grow.
Yoga proved life-changing in more ways than one
Greenwald, as you may have guessed, took her doctor's advice and made what would become the life-altering decision to try yoga.
'I happened to have this amazing yoga teacher in West Philly who was very mindfulness-based,' Greenwald said. 'No one was talking to me about anything that would have put me off — she just was like, 'this is what happens in your body when you breathe.''
Over the course of a year, she said, yoga changed her life, physically and cognitively.
'I was just a happier, healthier person because of this simple practice of breathing,' she said.
Greenwald knew it wasn't some kind of magic. There was science behind it, and she dove into the research. She wanted other people — especially 'wellness skeptics' like her, who had preconceived notions of yoga and thought it wasn't for them — to transform themselves, too.
The in-person early days
She started On the Goga in 2015 as a sort of special-order yoga instructor who would come to clients' homes, workplaces and events. Clients included an Eagles player, bachelorette parties, and eventually, company HR directors looking to add yoga to their employee offerings.
Very quickly, Greenwald saw the potential in employee yoga training. People who didn't 'get' yoga weren't likely to hire her, but through their employers, she could reach some of her fellow skeptics.
'I wanted to help other people realize that they already had all of the tools in themselves to change their lives,' she said. 'If I could deliver that through organizations that paid for this, for folks who would not otherwise be able to have access to these tools, that was the ultimate goal.'
As the business grew from a solopreneurship venture to a small team in the late 2010s, On the Goga established itself as a local wellness company that brought yoga and mindfulness to the boardrooms of Philly companies in the never-ending battle against employee burnout. Greenwald led many classes herself, in person on site or at company retreats.
It was about more than giving employees a break to center themselves. Greenwald recognized the potential of yoga and mindfulness to help companies thrive.
'Mindfulness is the foundation for all of the skills that help people to be leaders — empathy, perspective, foresight, objective thinking, boundary setting,' she said. 'We started doing leadership training, cooking, physical fitness, financial prosperity.'
There was no tech platform in the early days, but the small team thought about the possibilities of making one. Meditation apps were growing in popularity, but there wasn't an app out there that did what On the Goga did for employees.
Still, the in-person business model was working. That would all change in 2020, when the COVID pandemic hit.
A costly but high-potential shift
The in-person model of On the Goga didn't have much overhead, making it possible to bootstrap.
When the company had to go virtual during the COVID lockdowns in 2020, it became clear that to shift toward being a tech platform, it was going to need outside funding.
The first funding it received was a capital loan from the PIDC, a Philadelphia-based Community Development Financial Institution that helped the On the Goga team build the beta version of the tech platform.
'From that, it took off,' Greenwald said. 'We scaled with some incredible local partners.'
By 2022 — which Greenwald considers to be the founding of the new On the Goga — it had become clear that the platform had legs. She applied to the national Techstars accelerator, and On the Goga was accepted.
In 2023, it had its initial pre-seed. Its first seed round raised just under a million dollars from local investors, including Ben Franklin Technology Partners, Penn's Wharton Fund for Health and local angels. This year, it closed a $300,000 seed extension round in just three weeks.
'I think Philadelphia is one of the best cities in the world to start a business,' Greenwald said. 'We used the amazing Philadelphia network and community and some really fun, scrappy, guerrilla marketing tactics to get this thing off the ground.'
Preventing burnout and maintaining a healthy workplace
The On the Goga platform puts a wellness tool into the pockets of employees, with an app that can call up resources, wellness strategies and breathing exercises on demand, and allow them to attend live virtual workshops with coworkers.
The idea is not to treat burnout, but to prevent everyday stresses from snowballing into a mental health crisis.
'We call it 'pre-clinical,'' Greenwald said. 'What we found through our years of experience is that if you wait to solve people's problems reactively after they're already experiencing them, you're waiting too long when it comes to organizational intervention.'
More than anything, Greenwald seeks to redefine 'wellness' — a term that turns off a lot of people for a lot of reasons, from its 'hippie' associations to toxic workplace wellness programs that focus more on penalizing employees based on body mass index than on emotional safety.
'We want people to think of corporate wellness as, 'this is the best place to work,'' she said, noting that every expectation On the Goga places on its clients, it places on itself.
As the client platform incorporates more AI (among other things, Greenwald has given talks on 'AI for emotionally intelligent leadership'), much of it starts at home base, with AI tools helping with productivity.
A big focus right now, she said, is using AI to improve the bandwidth and burnout of On the Goga's own internal team.
'We're heavily leaning into developing workplace best practices around AI that are ethical, secure and supporting metrics on our team,' she said. 'Do you have enough time in the week to get things done? Do you have enough time in the week for creativity? And how is AI impacting these metrics that we know drive engagement and productivity over time?'
It's all part of the reimagining.
'Our mission statement,' Greenwald said, 'is to make the future of work more human.'
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Philly weekly roundup: Clean and Green shuts down; Interactive trash map; Capstan Therapeutics acquired
Philly weekly roundup: Clean and Green shuts down; Interactive trash map; Capstan Therapeutics acquired

Technical.ly

time08-07-2025

  • Technical.ly

Philly weekly roundup: Clean and Green shuts down; Interactive trash map; Capstan Therapeutics acquired

Welcome to the roundup of the latest from Philly's tech and entrepreneurship scene. Want this in your inbox? Subscribe for free. This week in Philly, a new tech training program comes to North Philly, an explainer on FCC v. Consumers' Research and more. Read on for weekly roundup of top news in the region. 📰 News Incubator: What else to know • Anna Greenwald was a wellness skeptic, but after yoga changed her life, she started employee wellness platform On the Goga to help others see the benefits, too. [ ] • Global biopharma company AbbVie will acquire local cell therapy company Capstan Therapeutics for $2.1 billion. [ Philly Biz Journal ] • Tayyib Smith and his business partner Jacob Roller are attempting to implement 'ethical development' in Kensington as a way to help close the city's racial wealth gap. [ The Inquirer ] • Civic data platform Clean and Green Philly announced it will be winding down this month due to lack of funding and capacity. The Code for Philly project analyzed data about vacant properties, but the city is no longer collecting and releasing that information. [ Github / / The Inquirer ] • Visual perception in AI is notably worse than human children, according to research by Vlad Ayzenberg, an assistant professor in Temple's Psychology and Neuroscience Department. [ Temple News ] • Stephon Proctor, a clinical psychologist at CHOP, developed a large language model tool that can be integrated with electronic health record system Epic. [ LinkedIn ] • Block cleanup startup Glitter released an interactive map showing the dump sites across the city where people can take their trash during the DC33 strike. Glitter clarified that the union does not support the use of these sites. [ Glitter / The Inquirer ] • Pennsylvania representative Chrissy Houlahan co-launched the BIOtech Caucus, which will support legislation related to biotech innovation in the United States. [ Chrissy Houlahan ] 🗓️ On the Calendar • event: Listen to CEO Chris Wink's conversation with Alice Gore, president and cofounder of Hello Alice, during the next Builder's Live on July 16. [ Register here ] • Partner event: Calling all web devs and open-source software fans — it's the end of an era: After nearly 20 years, this summer brings the last RailsConf. The sold-out event features a keynote by Ruby on Rails creator and Basecamp founder David Heinemeier Hansson, surrounded by 3 days of programming. [ Details here ] • Partner event: Best excuse to visit Chicago? Apply to the annual GPLEX conference and join local leaders to gain insights on how Philly can grow a vibrant economy, attract and retain talent and build an even stronger tech ecosystem. Deadline: July 21. [ Details here ] • Vote to choose the winner at Founders Live Philadelphia, a national pitch competition that will be in the city on July 8. [ Register ] • Mark your calendars for Code for Philly's July hack night. Join the civic tech group in person at Indy Hall on July 8. [ Register ] • Network with Philly's clean energy community at Renewables UnWind 2025 on July 10. [ Sign up ]

How On the Goga is reimagining corporate employee wellness programs
How On the Goga is reimagining corporate employee wellness programs

Technical.ly

time03-07-2025

  • Technical.ly

How On the Goga is reimagining corporate employee wellness programs

Startup profile: On the Goga Founded by: Anna Greenwald Year founded: 2015 Headquarters: Philadelphia, PA Sector: Healthcare Funding and valuation: $1.3 million in funding, according to the company Key ecosystem partners: PIDC, Ben Franklin Technology Partners, University of Pennsylvania Anna Greenwald didn't dream of being a wellness entrepreneur. She came to Philadelphia from Madison, Wisconsin, in 2011 as an aspiring opera singer with an interest in entrepreneurship, attending Drexel University's music industry program. When a vocal cord injury derailed her plans, leaving her emotionally devastated, Greenwald's physician insisted she start taking yoga. 'My first thought was, absolutely not,' Greenwald, now the founder and CEO of the corporate wellness platform On the Goga, told 'I'm not a hippie, and I hate exercise, so why would I try yoga?' On the Goga — the name a mashup of 'on the go' and 'yoga' — is now a national employee wellness platform serving a diverse array of clients, from small companies to large enterprises. With a recent $300,000 seed extension and a mission to transform corporate wellness, the company is leveraging technology, AI and a pre-clinical approach to employee well-being. While employee behavior tracking is becoming increasingly popular with corporations, On the Goga doesn't incorporate individual monitoring into its platform, instead collecting the broader organizational data, aggregating it and shares findings with clients that they can act on. 'We can share insights to employers to say, hey, the top driver of burnout for your employees is meeting schedules,' Greenwald said. While the platform doesn't flag clients when employees may need clinical intervention, it acts as an integrator, making clinical employee resources, such as therapy benefits offered by the company, visible on the platform. A decade and two business models in, the company continues to evolve and grow. Yoga proved life-changing in more ways than one Greenwald, as you may have guessed, took her doctor's advice and made what would become the life-altering decision to try yoga. 'I happened to have this amazing yoga teacher in West Philly who was very mindfulness-based,' Greenwald said. 'No one was talking to me about anything that would have put me off — she just was like, 'this is what happens in your body when you breathe.'' Over the course of a year, she said, yoga changed her life, physically and cognitively. 'I was just a happier, healthier person because of this simple practice of breathing,' she said. Greenwald knew it wasn't some kind of magic. There was science behind it, and she dove into the research. She wanted other people — especially 'wellness skeptics' like her, who had preconceived notions of yoga and thought it wasn't for them — to transform themselves, too. The in-person early days She started On the Goga in 2015 as a sort of special-order yoga instructor who would come to clients' homes, workplaces and events. Clients included an Eagles player, bachelorette parties, and eventually, company HR directors looking to add yoga to their employee offerings. Very quickly, Greenwald saw the potential in employee yoga training. People who didn't 'get' yoga weren't likely to hire her, but through their employers, she could reach some of her fellow skeptics. 'I wanted to help other people realize that they already had all of the tools in themselves to change their lives,' she said. 'If I could deliver that through organizations that paid for this, for folks who would not otherwise be able to have access to these tools, that was the ultimate goal.' As the business grew from a solopreneurship venture to a small team in the late 2010s, On the Goga established itself as a local wellness company that brought yoga and mindfulness to the boardrooms of Philly companies in the never-ending battle against employee burnout. Greenwald led many classes herself, in person on site or at company retreats. It was about more than giving employees a break to center themselves. Greenwald recognized the potential of yoga and mindfulness to help companies thrive. 'Mindfulness is the foundation for all of the skills that help people to be leaders — empathy, perspective, foresight, objective thinking, boundary setting,' she said. 'We started doing leadership training, cooking, physical fitness, financial prosperity.' There was no tech platform in the early days, but the small team thought about the possibilities of making one. Meditation apps were growing in popularity, but there wasn't an app out there that did what On the Goga did for employees. Still, the in-person business model was working. That would all change in 2020, when the COVID pandemic hit. A costly but high-potential shift The in-person model of On the Goga didn't have much overhead, making it possible to bootstrap. When the company had to go virtual during the COVID lockdowns in 2020, it became clear that to shift toward being a tech platform, it was going to need outside funding. The first funding it received was a capital loan from the PIDC, a Philadelphia-based Community Development Financial Institution that helped the On the Goga team build the beta version of the tech platform. 'From that, it took off,' Greenwald said. 'We scaled with some incredible local partners.' By 2022 — which Greenwald considers to be the founding of the new On the Goga — it had become clear that the platform had legs. She applied to the national Techstars accelerator, and On the Goga was accepted. In 2023, it had its initial pre-seed. Its first seed round raised just under a million dollars from local investors, including Ben Franklin Technology Partners, Penn's Wharton Fund for Health and local angels. This year, it closed a $300,000 seed extension round in just three weeks. 'I think Philadelphia is one of the best cities in the world to start a business,' Greenwald said. 'We used the amazing Philadelphia network and community and some really fun, scrappy, guerrilla marketing tactics to get this thing off the ground.' Preventing burnout and maintaining a healthy workplace The On the Goga platform puts a wellness tool into the pockets of employees, with an app that can call up resources, wellness strategies and breathing exercises on demand, and allow them to attend live virtual workshops with coworkers. The idea is not to treat burnout, but to prevent everyday stresses from snowballing into a mental health crisis. 'We call it 'pre-clinical,'' Greenwald said. 'What we found through our years of experience is that if you wait to solve people's problems reactively after they're already experiencing them, you're waiting too long when it comes to organizational intervention.' More than anything, Greenwald seeks to redefine 'wellness' — a term that turns off a lot of people for a lot of reasons, from its 'hippie' associations to toxic workplace wellness programs that focus more on penalizing employees based on body mass index than on emotional safety. 'We want people to think of corporate wellness as, 'this is the best place to work,'' she said, noting that every expectation On the Goga places on its clients, it places on itself. As the client platform incorporates more AI (among other things, Greenwald has given talks on 'AI for emotionally intelligent leadership'), much of it starts at home base, with AI tools helping with productivity. A big focus right now, she said, is using AI to improve the bandwidth and burnout of On the Goga's own internal team. 'We're heavily leaning into developing workplace best practices around AI that are ethical, secure and supporting metrics on our team,' she said. 'Do you have enough time in the week to get things done? Do you have enough time in the week for creativity? And how is AI impacting these metrics that we know drive engagement and productivity over time?' It's all part of the reimagining. 'Our mission statement,' Greenwald said, 'is to make the future of work more human.'

This startup's mission to extend human life sounds like sci-fi, and investors are betting $20M on it
This startup's mission to extend human life sounds like sci-fi, and investors are betting $20M on it

Technical.ly

time03-06-2025

  • Technical.ly

This startup's mission to extend human life sounds like sci-fi, and investors are betting $20M on it

Startup profile: Tolerance Bio Founded by: Francisco Leon Year founded: 2023 Headquarters: Philadelphia, PA Sector: Life sciences Funding and valuation: $20.2 million raised at an undisclosed valuation, according to the company Key ecosystem partners: Columbus Venture Partners, Ben Franklin Technology Partners When Francisco Leon talks about the medical science behind the biotech company he founded in 2023, it sounds like something out of a movie. The company, Tolerance Bio, focuses on preserving the body's immune system by restoring the function of an organ called the thymus. The organ, long believed to be as useful in adults as the appendix (that is, not at all), may actually be the key to slower aging and prolonged life spans. 'Immune tolerance is at the core of almost all medical needs,' Leon told Now, Tolerance Bio is moving toward the first trials of its proprietary stem cell therapy, focusing first on children born without a thymus. The thymus, a small gland located behind the breastbone in the upper chest, controls immune tolerance by creating T-cells, white blood cells that fight infections and cancerous cells, and can also prevent the body from attacking healthy cells. It's a vital organ, but even in a perfectly healthy person, it only functions at 100% for the first two years of life, and then, Leon said, it starts to shrink. By adulthood, the thymus functions at just 10%, which is why the medical community didn't think it was needed in adults. That changed in 2023, when an article published in the New England Journal of Medicine concluded that the surgical removal of the residue of the thymus in adults led to an increase in the five-year mortality rates due to cancer and autoimmunity. Subsequent research in nursing homes, Leon said, found that the better the thymic function, the lower the incidence of cancer, autoimmunity and infection. 'That's why we started the company,' Leon said, 'we are trying to restore thymic function.' From genetic diseases to anti-aging One of the main focuses of Tolerance Bio's research and development is using its cell implantation therapy to cure DiGeorge syndrome, also known as 22q11.2 deletion syndrome, a genetic condition where a baby is born without a thymus, or with one that is underdeveloped. Children with this condition struggle to fight infections and often have heart problems or other serious medical issues. Restoring the thymus has the potential to save babies who, with cases of complete DiGeorge syndrome, have a life expectancy of two to three years without medical intervention. Since the thymus naturally loses functionality as a person ages, Leon and his team also aim to develop treatments for adults, including a drug for healthy people that could potentially delay aging and increase longevity. 'We can regenerate the thymus by implanting cells intramuscularly; it's a new science,' Leon said. It's yet to be proven in humans, but if they can show the principle in human patients, he said, they can potentially apply it to other conditions, including Type 1 diabetes, cancer, organ diseases, other immune deficiencies, and, potentially, Alzheimer's disease. A $20 million seed round Leon, who leads a hybrid team of 10 from Tolerance Bio headquarters at the B+labs incubator at the Cira Centre in Philadelphia, is an immunologist who came to the US from Spain 25 years ago. After starting out working for pharmaceutical companies, including helping to develop drugs in immunology and oncology, he became an entrepreneur, cofounding the drug development companies Celimmune (acquired by Amgen in 2017) and Provention (acquired by Sanofi in 2023). Provention developed the drug Tzield, which can delay the onset of Type 1 diabetes in at-risk patients. 'It was the first drug ever to delay the onset of an autoimmune disease,' Leon said. 'You give it to children that show signs of being about to become diabetic, but still don't need insulin.' By the time Sanofi acquired Provention, Leon was ready to turn his focus to preventing and regenerating the thymus. He started Tolerance Bio, initially as a concept, bringing two members of the Provention team with him and partnering with University of Florida academic Holger Russ as Tolerance Bio's scientific cofounder. Tolerance Bio closed a $20.2 million seed round in December 2024. Led by Columbus Venture Partners, it included Ben Franklin Technology Partners, Criteria Bio Ventures, Sessa Capital, BioAdvance, Pacific 8 Ventures and individual biotechnology investors with an interest in thymus regeneration. 'We now know that thymic evolution is the main limiter of human life — it is the beginning of aging,' Leon said. 'There is a strong correlation between thymic function and longevity in humans and animals.' 'This almost sounds like science fiction' Even the Tolerance Bio team is amazed at the potential. 'This almost sounds like science fiction, in some respects,' said Phil Ball, Tolerance Bio's SVP and head of business development and operations, who previously worked with Leon at Provention. 'The technology that science needed to get to this point is, even for me, who's worked in the industry for so long, is absolutely amazing.' Translating that technology into actual products that reach as many patients as possible is a priority for the team. 'Ultimately, if we don't have approved products, it's been wasted time,' said Ball, who has spent 25 years in the industry, starting in the UK, where he worked for small biotech companies before moving to the US and eventually settling in Chapel Hill, North Carolina. The team's expert on scaling up clinical manufacturing, Poh Yeh-Chuin, is based in Cambridge, Massachusetts. He previously worked for Beam Therapeutics, where he led a cell process development group that developed products currently being manufactured — one, a stem cell program for sickle cell disease, the other a CAR-T therapy program for cancer treatment. Prior to that, he was part of the startup Semma Therapeutics (since acquired by Vertex), helping to develop a Type 1 diabetes treatment using pancreatic stem cells. 'It's very related to the work that we're doing here at Tolerance,' Poh said. 'Especially the cell therapy part, because both the pancreas as well as the thymus are derived from what we call the endoderm lineage.' Simply put, the endocrine system — including the pancreas, the thymus and the thyroid — comes from the same type of embryonic cells, which can be used in the treatment of endocrine disorders. Justin Vogel, Tolerance's chief financial officer and the other former Provention team member, grew up at the Jersey Shore and still lives in New Jersey. While the team is spread out, Vogel frequently comes to work at the Philadelphia office. While much of what they do at Tolerance Bio is focused on complex biotechnology, Vogel also stressed the importance of getting involved with the people and organizations they are trying to help. Members of the team attended the recent 22q at The Zoo event in Philadelphia, part of a global awareness event held at zoos around the world led by the International 22q11.2 Foundation. 'We're a very patient-focused organization,' Vogel said. 'It's so important to hear all the stories and meet the families, and it really resonates with us and gives meaning to what we try to do for these kids.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store